Auto - Dealerships
Compare Stocks
4 / 10Stock Comparison
BGSI vs AMZN vs MSFT vs COLL
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Software - Infrastructure
Drug Manufacturers - Specialty & Generic
BGSI vs AMZN vs MSFT vs COLL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Auto - Dealerships | Specialty Retail | Software - Infrastructure | Drug Manufacturers - Specialty & Generic |
| Market Cap | $3.11B | $2.86T | $3.03T | $1.16B |
| Revenue (TTM) | $3.15B | $742.78B | $318.27B | $796M |
| Net Income (TTM) | $19M | $90.80B | $125.22B | $75M |
| Gross Margin | 39.2% | 50.6% | 68.3% | 60.7% |
| Operating Margin | 4.2% | 11.5% | 46.8% | 23.8% |
| Forward P/E | 26.1x | 30.6x | 24.3x | 4.8x |
| Total Debt | $1.71B | $152.99B | $112.18B | $941M |
| Cash & Equiv. | $1.23B | $86.81B | $30.24B | $251M |
BGSI vs AMZN vs MSFT vs COLL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Amazon.com, Inc. (AMZN) | 100 | 217.7 | +117.7% |
| Microsoft Corporati… (MSFT) | 100 | 222.5 | +122.5% |
| Collegium Pharmaceu… (COLL) | 100 | 161.9 | +61.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BGSI vs AMZN vs MSFT vs COLL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BGSI is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.82, Low D/E 99.8%, current ratio 3.14x
- Beta 0.82, yield 0.4%, current ratio 3.14x
AMZN is the clearest fit if your priority is momentum.
- +27.4% vs BGSI's -25.1%
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.85, yield 0.8%
- 7.4% 10Y total return vs AMZN's 6.4%
- 39.3% margin vs BGSI's 0.6%
- 0.8% yield, 19-year raise streak, vs BGSI's 0.4%, (2 stocks pay no dividend)
COLL is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 23.6%, EPS growth -7.0%, 3Y rev CAGR 18.9%
- PEG 0.27 vs MSFT's 1.29
- 23.6% revenue growth vs BGSI's 4.2%
- Lower P/E (4.8x vs 24.3x), PEG 0.27 vs 1.29
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.6% revenue growth vs BGSI's 4.2% | |
| Value | Lower P/E (4.8x vs 24.3x), PEG 0.27 vs 1.29 | |
| Quality / Margins | 39.3% margin vs BGSI's 0.6% | |
| Stability / Safety | Beta 0.61 vs AMZN's 1.50 | |
| Dividends | 0.8% yield, 19-year raise streak, vs BGSI's 0.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +27.4% vs BGSI's -25.1% | |
| Efficiency (ROA) | 19.2% ROA vs BGSI's 0.7%, ROIC 24.9% vs 103.7% |
BGSI vs AMZN vs MSFT vs COLL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BGSI vs AMZN vs MSFT vs COLL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 3 of 6 categories
COLL leads 1 • AMZN leads 1 • BGSI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 932.7x COLL's $796M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to BGSI's 0.6%. On growth, MSFT holds the edge at +18.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.2B | $742.8B | $318.3B | $796M |
| EBITDAEarnings before interest/tax | $381M | $155.9B | $192.6B | $529M |
| Net IncomeAfter-tax profit | $19M | $90.8B | $125.2B | $75M |
| Free Cash FlowCash after capex | $287M | -$2.5B | $72.9B | $330M |
| Gross MarginGross profit ÷ Revenue | +39.2% | +50.6% | +68.3% | +60.7% |
| Operating MarginEBIT ÷ Revenue | +4.2% | +11.5% | +46.8% | +23.8% |
| Net MarginNet income ÷ Revenue | +0.6% | +12.2% | +39.3% | +9.4% |
| FCF MarginFCF ÷ Revenue | +9.1% | -0.3% | +22.9% | +41.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | +16.6% | +18.3% | +8.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +81.8% | +74.8% | +23.4% | +4.4% |
Valuation Metrics
COLL leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 20.6x trailing earnings, COLL trades at a 85% valuation discount to BGSI's 134.5x P/E. Adjusting for growth (PEG ratio), COLL offers better value at 1.15x vs MSFT's 1.59x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.1B | $2.86T | $3.03T | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $2.92T | $3.11T | $1.8B |
| Trailing P/EPrice ÷ TTM EPS | 134.53x | 37.07x | 29.90x | 20.63x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.14x | 30.62x | 24.33x | 4.80x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.33x | 1.59x | 1.15x |
| EV / EBITDAEnterprise value multiple | 1.12x | 20.07x | 19.12x | 4.47x |
| Price / SalesMarket cap ÷ Revenue | 0.97x | 3.99x | 10.75x | 1.48x |
| Price / BookPrice ÷ Book value/share | 1.46x | 7.00x | 8.86x | 4.70x |
| Price / FCFMarket cap ÷ FCF | 11.25x | 371.50x | 42.30x | 3.53x |
Profitability & Efficiency
MSFT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $2 for BGSI. MSFT carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to COLL's 3.12x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs BGSI's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.8% | +23.3% | +33.1% | +26.7% |
| ROA (TTM)Return on assets | +0.7% | +11.5% | +19.2% | +4.6% |
| ROICReturn on invested capital | +103.7% | +14.7% | +24.9% | +14.0% |
| ROCEReturn on capital employed | +109.1% | +15.3% | +29.7% | +15.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.00x | 0.37x | 0.33x | 3.12x |
| Net DebtTotal debt minus cash | $487M | $66.2B | $81.9B | $689M |
| Cash & Equiv.Liquid assets | $1.2B | $86.8B | $30.2B | $251M |
| Total DebtShort + long-term debt | $1.7B | $153.0B | $112.2B | $941M |
| Interest CoverageEBIT ÷ Interest expense | 41.61x | 39.96x | 55.65x | 1.65x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,667 today (with dividends reinvested), compared to $7,608 for BGSI. Over the past 12 months, AMZN leads with a +27.4% total return vs BGSI's -25.1%. The 3-year compound annual growth rate (CAGR) favors AMZN at 34.1% vs BGSI's -8.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -29.2% | +17.4% | -13.6% | -21.6% |
| 1-Year ReturnPast 12 months | -25.1% | +27.4% | -8.5% | +20.7% |
| 3-Year ReturnCumulative with dividends | -24.5% | +141.1% | +35.1% | +54.7% |
| 5-Year ReturnCumulative with dividends | -23.9% | +68.7% | +76.7% | +63.4% |
| 10-Year ReturnCumulative with dividends | -23.3% | +640.4% | +737.3% | +137.8% |
| CAGR (3Y)Annualised 3-year return | -8.9% | +34.1% | +10.5% | +15.7% |
Risk & Volatility
Evenly matched — AMZN and COLL each lead in 1 of 2 comparable metrics.
Risk & Volatility
COLL is the less volatile stock with a 0.61 beta — it tends to amplify market swings less than AMZN's 1.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 95.4% from its 52-week high vs BGSI's 61.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 1.50x | 0.85x | 0.61x |
| 52-Week HighHighest price in past year | $183.10 | $278.56 | $555.45 | $50.79 |
| 52-Week LowLowest price in past year | $110.80 | $197.28 | $356.28 | $28.34 |
| % of 52W HighCurrent price vs 52-week peak | +61.0% | +95.4% | +73.4% | +70.3% |
| RSI (14)Momentum oscillator 0–100 | 35.7 | 68.8 | 52.2 | 52.9 |
| Avg Volume (50D)Average daily shares traded | 38K | 44.6M | 32.0M | 537K |
Analyst Outlook
MSFT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BGSI as "Buy", AMZN as "Buy", MSFT as "Buy", COLL as "Buy". Consensus price targets imply 62.5% upside for COLL (target: $58) vs 15.4% for AMZN (target: $307). For income investors, MSFT offers the higher dividend yield at 0.79% vs BGSI's 0.38%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $166.50 | $306.77 | $556.88 | $58.00 |
| # AnalystsCovering analysts | 1 | 94 | 81 | 12 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | — | +0.8% | — |
| Dividend StreakConsecutive years of raises | 0 | — | 19 | 0 |
| Dividend / ShareAnnual DPS | $0.42 | — | $3.23 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.6% | +2.2% |
MSFT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). COLL leads in 1 (Valuation Metrics). 1 tied.
BGSI vs AMZN vs MSFT vs COLL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BGSI or AMZN or MSFT or COLL a better buy right now?
For growth investors, Collegium Pharmaceutical, Inc.
(COLL) is the stronger pick with 23. 6% revenue growth year-over-year, versus 4. 2% for Boyd Group Services Inc. (BGSI). Collegium Pharmaceutical, Inc. (COLL) offers the better valuation at 20. 6x trailing P/E (4. 8x forward), making it the more compelling value choice. Analysts rate Boyd Group Services Inc. (BGSI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BGSI or AMZN or MSFT or COLL?
On trailing P/E, Collegium Pharmaceutical, Inc.
(COLL) is the cheapest at 20. 6x versus Boyd Group Services Inc. at 134. 5x. On forward P/E, Collegium Pharmaceutical, Inc. is actually cheaper at 4. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Collegium Pharmaceutical, Inc. wins at 0. 27x versus Microsoft Corporation's 1. 29x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BGSI or AMZN or MSFT or COLL?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +76.
7%, compared to -23. 9% for Boyd Group Services Inc. (BGSI). Over 10 years, the gap is even starker: MSFT returned +737. 3% versus BGSI's -23. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BGSI or AMZN or MSFT or COLL?
By beta (market sensitivity over 5 years), Collegium Pharmaceutical, Inc.
(COLL) is the lower-risk stock at 0. 61β versus Amazon. com, Inc. 's 1. 50β — meaning AMZN is approximately 146% more volatile than COLL relative to the S&P 500. On balance sheet safety, Microsoft Corporation (MSFT) carries a lower debt/equity ratio of 33% versus 3% for Collegium Pharmaceutical, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BGSI or AMZN or MSFT or COLL?
By revenue growth (latest reported year), Collegium Pharmaceutical, Inc.
(COLL) is pulling ahead at 23. 6% versus 4. 2% for Boyd Group Services Inc. (BGSI). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to -27. 2% for Boyd Group Services Inc.. Over a 3-year CAGR, COLL leads at 18. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BGSI or AMZN or MSFT or COLL?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus 0. 6% for Boyd Group Services Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BGSI leads at 92. 2% versus 11. 2% for AMZN. At the gross margin level — before operating expenses — MSFT leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BGSI or AMZN or MSFT or COLL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Collegium Pharmaceutical, Inc. (COLL) is the more undervalued stock at a PEG of 0. 27x versus Microsoft Corporation's 1. 29x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Collegium Pharmaceutical, Inc. (COLL) trades at 4. 8x forward P/E versus 30. 6x for Amazon. com, Inc. — 25. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COLL: 62. 5% to $58. 00.
08Which pays a better dividend — BGSI or AMZN or MSFT or COLL?
In this comparison, MSFT (0.
8% yield), BGSI (0. 4% yield) pay a dividend. AMZN, COLL do not pay a meaningful dividend and should not be held primarily for income.
09Is BGSI or AMZN or MSFT or COLL better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
85), 0. 8% yield, +737. 3% 10Y return). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +737. 3%, AMZN: +640. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BGSI and AMZN and MSFT and COLL?
These companies operate in different sectors (BGSI (Consumer Cyclical) and AMZN (Consumer Cyclical) and MSFT (Technology) and COLL (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BGSI is a small-cap quality compounder stock; AMZN is a mega-cap quality compounder stock; MSFT is a mega-cap quality compounder stock; COLL is a small-cap high-growth stock. MSFT pays a dividend while BGSI, AMZN, COLL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.